Cost-effectiveness evaluation involving cinacalcet regarding haemodialysis sufferers together with moderate-to-severe extra hyperparathyroidism inside Cina: evaluation in line with the EVOLVE trial.
https://www.selleckchem.com/products/auranofin.html